Brief: Delaware District Court Rules In Favor Of Acadia In Nuplazid Formulation Patent Litigation
16/05/2025 18:45
May 16 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O: DELAWARE DISTRICT COURT RULES IN FAVOR OF ACADIA IN NUPLAZID® (PIMAVANSERIN) FORMULATION PATENT LITIGATION ACADIA PHARMACEUTICALS INC - COURT UPHOLDS ACADIA'S '721 FORMULATION PATENT FOR NUPLAZID Source text: ID:nBwk22TBa Further company coverage: ACAD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry